105 related articles for article (PubMed ID: 19138314)
1. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.
Demir T; Akinci B; Comlekci A; Karaoglu O; Ozcan MA; Yener S; Yuksel F; Secil M; Yesil S
Clin Endocrinol (Oxf); 2009 Sep; 71(3):446-50. PubMed ID: 19138314
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Effect of levothyroxine suppression therapy on plasma thrombin activatable fibrinolysis inhibitor antigen levels in benign thyroid nodules.
Akinci B; Demir T; Comlekci A; Yener S; Ozcan MA; Karaoglu O; Yuksel F; Secil M; Yesil S
Med Princ Pract; 2011; 20(1):23-8. PubMed ID: 21160209
[TBL] [Abstract][Full Text] [Related]
4. [The effect of levothyroxine suppression therapy for benign thyroid nodules on bone metabolism in premenopausal women].
Akinci B; Demir T; Cömlekçi A; Karaoğlu O; Seçil M; Yeşil S
Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):232-7. PubMed ID: 19052491
[TBL] [Abstract][Full Text] [Related]
5. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
Choi JW; Pai SH
Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis.
Krysiak R; Okopien B
Thromb Haemost; 2012 Nov; 108(5):973-80. PubMed ID: 22918596
[TBL] [Abstract][Full Text] [Related]
9. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
10. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
12. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study.
Van Zaane B; Squizzato A; Debeij J; Dekkers OM; Meijers JC; Van Zanten AP; Büller HR; Gerdes VE; Cannegieter SC; Brandjes DP
J Thromb Haemost; 2011 Sep; 9(9):1816-24. PubMed ID: 21729238
[TBL] [Abstract][Full Text] [Related]
13. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
Fast S; Bonnema SJ; Hegedüs L
Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
[TBL] [Abstract][Full Text] [Related]
14. [Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].
Lewiński A
Wiad Lek; 2001; 54 Suppl 1():21-30. PubMed ID: 12182027
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
[TBL] [Abstract][Full Text] [Related]
16. Metformin treatment for small benign thyroid nodules in patients with insulin resistance.
Rezzónico J; Rezzónico M; Pusiol E; Pitoia F; Niepomniszcze H
Metab Syndr Relat Disord; 2011 Feb; 9(1):69-75. PubMed ID: 21128816
[TBL] [Abstract][Full Text] [Related]
17. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
[TBL] [Abstract][Full Text] [Related]
18. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample.
Panasevich S; Leander K; Rosenlund M; Ljungman P; Bellander T; de Faire U; Pershagen G; Nyberg F
Occup Environ Med; 2009 Nov; 66(11):747-53. PubMed ID: 19687019
[TBL] [Abstract][Full Text] [Related]
19. Influence of smoking during pregnancy on haemostasis in healthy full term neonates.
Mitsiakos G; Giougi E; Papaioannou G; Karagianni P; Papadakis E; Nikolaidis N
Thromb Res; 2009; 123(3):476-81. PubMed ID: 18417192
[TBL] [Abstract][Full Text] [Related]
20. [Thyroxine therapy in benign thyroid nodules].
Vulpoi C; Zbranca E; Mogoş V; Preda C; Găleşanu C; Ungureanu MC; Ciobanu DG; Brănişteanu DD
Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):95-100. PubMed ID: 12092166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
